GPR75 and Obesity: Protein truncating variants (PTVs) in GPR75 were detected in approximately 4 per 10,000 individuals, who exhibited an average BMI reduction of 1.8 kg/m2, a weight decrease of 5.3 kg, and a 54% lower obesity risk compared to non-carriers [74].